News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
BOYER ANDREW S
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
4
| BOYER ANDREW S (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Sold 29,302 shares
@ $4.1267, valued at
$120.9k
|
|
| 08/11/2023 |
144/A
| Form 144/A - Report of proposed sale of securities: [Amend] |
| 08/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/05/2023 |
4
| BOYER ANDREW S (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 11,571 shares
@ $3.1, valued at
$35.9k
Exercised 23,095 restricted stock units
@ $0 |
|
| 03/07/2023 |
4
| BOYER ANDREW S (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 19,685 shares
@ $1.92, valued at
$37.8k
Exercised 39,251 restricted stock units
@ $0
Granted 198,777 restricted stock units
@ $0
Granted 397,554 options to buy
@ $0 |
|
| 03/01/2023 |
4
| BOYER ANDREW S (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 17,557 shares
@ $2.16, valued at
$37.9k
Exercised 31,662 restricted stock units
@ $0 |
|
| 07/05/2022 |
4
| BOYER ANDREW S (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 11,582 shares
@ $3.18, valued at
$36.8k
Exercised 23,094 restricted stock units
@ $0 |
|
| 05/10/2022 |
4
| BOYER ANDREW S (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 8,353 shares
@ $3.4, valued at
$28.4k
Exercised 16,656 restricted stock units
@ $0 |
|
| 03/03/2022 |
4
| BOYER ANDREW S (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 6,192 shares
@ $4.45, valued at
$27.6k
Paid exercise price by delivering 15,733 shares
@ $4.45, valued at
$70k
Exercised 12,346 restricted stock units
@ $0
Exercised 31,370 restricted stock units
@ $0
Granted 157,005 restricted stock units
@ $0
Granted 314,010 options to buy
@ $0 |
|
| 03/01/2022 |
4
| BOYER ANDREW S (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 16,434 shares
@ $4.59, valued at
$75.4k
Exercised 31,662 restricted stock units
@ $0 |
|
| 07/01/2021 |
4
| BOYER ANDREW S (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 11,583 shares
@ $5.12, valued at
$59.3k
Exercised 23,095 restricted stock units
@ $0 |
|
| 05/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| BOYER ANDREW S (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 125,483 restricted stock units
@ $0
Granted 250,966 options to buy
@ $0 |
|
| 03/02/2021 |
4
| BOYER ANDREW S (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 16,301 shares
@ $5.39, valued at
$87.9k
Paid exercise price by delivering 6,192 shares
@ $5.18, valued at
$32.1k
Exercised 31,662 restricted stock units
@ $0
Exercised 12,346 restricted stock units
@ $0 |
|
| 08/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/08/2020 |
4
| BOYER ANDREW S (Exec VP, Comm Optns) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 8,353 shares
@ $3.55, valued at
$29.7k
Exercised 16,656 restricted stock units
@ $0 |
|
| 03/03/2020 |
4
| BOYER ANDREW S (Exec VP, Comm Optns) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 6,683 shares
@ $3.85, valued at
$25.7k
Exercised 12,345 restricted stock units
@ $0 |
|
| 03/02/2020 |
4
| BOYER ANDREW S (Exec VP, Comm Optns) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 126,649 restricted stock units
@ $0
Granted 253,298 options to buy
@ $0 |
|
| 11/14/2019 |
4
| BOYER ANDREW S (Exec VP, Comm Optns) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 272,480 options
@ $15.01, valued at
$4.1M
Granted 272,480 options
@ $2.75, valued at
$749.3k
Disposed/sold 100,553 options
@ $13.5, valued at
$1.4M
Granted 100,553 options
@ $2.75, valued at
$276.5k
|
|
| 08/07/2019 |
4
| BOYER ANDREW S (Exec VP, Comm Optns) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Bought 66,666 shares
@ $2.89, valued at
$192.7k
|
|
| 05/13/2019 |
4
| BOYER ANDREW S (Exec VP, Comm Optns) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Bought 19,000 shares
@ $9.46, valued at
$179.7k
|
|
| 05/09/2019 |
4
| BOYER ANDREW S (Exec VP, Comm Optns) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 8,353 shares
@ $13.44, valued at
$112.3k
Exercised 16,655 restricted stock units
@ $0 |
|
| 03/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/08/2018 |
4
| BOYER ANDREW S (Exec VP, Comm Optns) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 2,000 shares
@ $0
Granted 272,480 options
@ $15.01, valued at
$4.1M
Granted 66,622 restricted stock units
@ $0 |
|
| 05/08/2018 |
3
| BOYER ANDREW S (Exec VP, Comm Optns) has filed a Form 3 on Amneal Pharmaceuticals, Inc. |
| 03/16/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/26/2010 |
4
| BOYER ANDREW S (SVP,Sales&Mktg,US Generics) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Granted 10,015 shares
@ $0 |
|
| 08/13/2009 |
4
| BOYER ANDREW S (SVP,Sales&Mktg,US Generics) has filed a Form 4 on WATSON PHARMACEUTICALS INC |
|
|